Head And Neck Cancers
Among patients receiving a swallow evaluation, feeding tube requirements were less frequent for those receiving a pretreatment evaluation compared with referral during or after treatment (31% versus 61 and 64%, respectively).
"This case reinforces the role of tissue culture when histology fails to demonstrate a diagnosis and emphasizes the need for efficient communication between the pediatrician, otolaryngologist, and pathologist for timely excision," the authors write.
Cannabidiol could be beneficial for the treatment of oral mucositis, although data on its use in dentistry are scarce, according to a review published online February 12 in the Journal of Clinical Pharmacy and Therapeutics.
For patients taking antiretroviral medications, HIV continues to reside in tissues, and though this may not cause AIDS, it could contribute to the development of unrelated conditions such as cancer and cardiovascular disease, according to research published in the October issue of the Journal of Virology.
Merck announced that the Food and Drug Administration (FDA) has approved Keytruda (pembrolizumab) for the treatment of patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) with disease progression on or after platinum-containing chemotherapy.
Amneal Biosciences announced that due to the current shortage of Bleomycin Sulfate for Injection, USP, 15 Units and 30 Units per vial, they have initiated a temporary importation of Bleomycin Sulfate Powder for Injection 15,000 IU per vial to the market.
The majority of cancers linked to human papillomavirus (HPV) are preventable, according to a report published in the July 8 issue of the US Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.
Researchers have identified immune genes that may affect mortality in patients with glioblastoma multiforme, according to a study published online in Neurology.
Fewer thyroid cancers are diagnosed in the United States now than in the recent past, perhaps signaling a change in physician practices.
Adding chemotherapy to radiation treatment may add years to the lives of patients with grade 2 gliomas, according to research published in the April 7 issue of the New England Journal of Medicine.
Image-guided surveillance seems beneficial for patients with squamous-cell carcinoma of the head and neck who have advanced nodal disease, according to a study published online in the New England Journal of Medicine.
Overall rates of cancer and cancer mortality in the United States continue to decline, according to the Annual Report to the Nation on the Status of Cancer.
Higher body weight and taller stature during adolescence are associated with increased risk of non-Hodgkin's lymphoma (NHL), according to a study published online in 'Cancer'.
Vitamin E supplementation can reduce cisplatin (CDDP)-induced ototoxicity, according to a study published online in Head & Neck.
Bristol-Myers Squibb announced that the CheckMate -141 trial evaluating Opdivo (nivolumab) vs. investigator's choice in patients with recurrent or metastatic platinum-refractory squamous cell carcinoma of the head and neck (SCCHN) was stopped early due to the study meeting its primary endpoint.
Pediatric patients with nasopharyngeal carcinoma (NPC) are more often black and present with stage IV disease, but they have lower mortality than adult patients, according to a study published online in JAMA Otolaryngology-Head & Neck Surgery.
For patients with oral cancer, fluorescence visualization (FV)-guided surgery is associated with a reduction in local recurrence, according to a study published online January 14 in JAMA Otolaryngology-Head & Neck Surgery.
There is geographic variation in the proportion of head and neck cancers attributable to human papillomavirus (HPV)
For patients with head and neck cancer (HNC) treated with intensity-modulated radiation therapy (IMRT), provider volume is associated with outcome, according to a study published online January 4 in the Journal of Clinical Oncology.
Eagle Pharmaceuticals announced that the Food and Drug Administration (FDA) has approved Docetaxel Injection, Non-Alcohol Formula, for the treatment of breast cancer, non-small cell lung cancer, prostate cancer, gastric adenocarcinoma, and head and neck cancer.
The FDA has approved Wellstat Therapeutics' Vistogard (uridine triacetate) oral granules, the first treatment for patients following an overdose of 5-fluorouracil (5-FU) or capecitabine,
A statistical tool can accurately estimate an individual patient's risk of developing a major complication after surgery for oral cavity squamous cell carcinoma.
For patients with incurable head and neck cancer, high-dose hypofractionated radiotherapy (RT) is associated with meaningful palliative effect.
Significant disparities in care and outcomes exist for children with retinoblastoma, according to a study published in JAMA Pediatrics.
For patients treated for head and neck squamous cell carcinoma (HNSCC), no definite index of symptoms or signs indicates local recurrence or second primary malignancy.
Metformin is associated with a lower risk of developing head and neck cancer in patients with diabetes, according to a study published in Head & Neck.